Join Our Diverse Capable Site Network


Supporting sites through experiences and relationships

Your site is our most valuable asset
to advancing clinical, diversity, and inclusion in research

Take the first step in improving the diversity of your site. Join Our Diverse Capable Site Network.

The #1 request we are hearing from Sponsors/CROs this year is around identification and access to sites that have racial and ethnically diverse patient populations. Total Diversity (TD) is building a diverse capable site network of research sites with access and interest in recruiting and enrolling diverse populations. Currently there are 250 sites in our network, all with various therapeutic capabilities.

There is no consequence to a lower score on the DSAT, so don’t be intimidated to complete it. TD has developed training around best practices for the recruitment and enrollment of diverse patient populations into a clinical trial to support sites with various levels of awareness and experience. Our goal is to support sites in applying these practices, improving your DSAT score, and being offered additional trial opportunities because of your new skills.

The first step to becoming part of TD diverse capable site network is to answer a few site profile and diversity metric questions and self-assess your site’s diversity awareness and current practices by completing the Diversity Site Assessment Tool (DSAT)* through Total Diversity. Once this is completed, TD will provide your DSAT score results so your site identify areas for improvement.

*Diversity Site Assessment Tool (DSAT) is a product developed by the Society for Clinical Research Sites (SCRS) Diversity initiative group.

**Must be completed in full at

Diana L. Foster, Ph.D

CEO and Chief Diversity Officer for TOTAL Diversity Clinical Trial Management

Diana L. Foster, Ph.D., is the CEO and Chief Diversity Officer for TOTAL Diversity Clinical Trial Management, a full-service Diversity Organization whose mission is to enhance diversity and inclusion in clinical research trials. Foster has served as the Vice President of Diversity, Equity, and Inclusion for the Society of Clinical Research Sites (SCRS) since 2016. She also held a position as the Vice President of Strategy and Development for SCRS originating programs such as the Global Impact Partner Programs and many other industry supported initiatives.

Foster is a thought-leader and sought-after expert in diversity and clinical site best practices. She is the author of the Diversity Site Assessment Tool and has published numerous research papers on the topic. Over the past two decades, she has addressed audiences across the world, published multiple papers and articles, and written five authoritative industry books including Global Issues in Patient Recruitment and Retention.

Jerome Adams, M.D.

Chairman of the Board for TOTAL Diversity Clinical Trial Management

Dr. Adams also currently serves as Executive Director of Health Equity Initiatives at Purdue University. He formerly served as the 20th United States Surgeon General and as a member of the President’s COVID-19 task force, where he was at the forefront of America’s most pressing health challenges throughout the pandemic, including working with companies to increase diversity in vaccine trials.

As the Chairman of the Board for TOTAL Diversity, Dr. Adams provides his in-depth knowledge of patient perspectives and industry views on diversity to create sustainable solutions and best practices to establish more diverse representation in clinical trials.